Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq
Insider Sale
+$4,024
-0.02%
Shares
Shares Volume: 1,006 Shares
Average Share Price: $4
INSIDER
Sommadossi Jean-Pierre
President, CEO, and Chairman (Director)
reported on Jun 7 2024
traded on Jun 5 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 6,040,551 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $111,563.75 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $70,296.2 |
| COMPANY PREVIOUS TRADES |